Showing results (11-20 of 189) with videos related to
Sort By:
Pageof 19
International Journal of Clinical Oncology|June 13, 2026
Mirvetuximab soravtansine in platinum-resistant ovarian cancer: from biological rationale to clinical impact and future directionsSeiji Mabuchi, Ai Kusakabe, Tomoyuki SasanoCurrent Opinion in Obstetrics & Gynecology|September 23, 2009
Use of monoclonal antibodies in the treatment of ovarian cancerSeiji Mabuchi, Kenichirou Morishige, Tadashi KimuraJSLS : Journal of the Society of Laparoendoscopic Surgeons|April 9, 2020
New Peritoneal Traction Device for Laparoscopic Paraaortic LymphadenectomySeiji Mabuchi, Yuri Matsumoto, Sho MatsubaraJournal of Gynecology Obstetrics and Human Reproduction|June 25, 2021
The significance of post-radiotherapy parametrial involvement and the necessity of parametrial resection in locally-recurrent or persistent cervical cancer developed after radiotherapySeiji Mabuchi, Kotaro Shimura, Yuri MatsumotoJSLS : Journal of the Society of Laparoendoscopic Surgeons|March 13, 2020
A New Silicon Sling Device for Traction During Robotic Gynecologic SurgerySeiji Mabuchi, Yuri Matsumoto, Sho MatsubaraJournal of Gynecologic Oncology|July 9, 2010
Carboplatin and paclitaxel as an initial treatment in patients with stage IVb cervical cancer: a report of 7 cases and a review of the literatureSeiji Mabuchi, Kenichirou Morishige, Takayuki Enomoto, et al.Anticancer Research|September 3, 2021
Preclinical Activity of Plitidepsin Against Clear Cell Carcinoma of the OvaryRyuta Miyake, Shoichiro Yamanaka, Sho Matsubara, et al.Obstetrics & Gynecology Science|September 14, 2021
Prognostic significance of tumor laterality in advanced ovarian cancerYuki Yamada, Seiji Mabuchi, Naoki Kawahara, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 4, 2018
Myeloid-derived suppressor cells and their role in gynecological malignanciesSeiji Mabuchi, Eriko Yokoi, Naoko Komura, et al.Gynecologic Oncology|February 14, 2015
The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancerSeiji Mabuchi, Hiromasa Kuroda, Ryoko Takahashi, et al.Pageof 19